Participate in a Study
We invite people of all ages and backgrounds to participate in the exciting research studies being conducted here at Pennington Biomedical. The studies are at no charge to you and many of them offer compensation for volunteers who participate. Below are our ongoing pediatric clinical studies:
The AWARD-PEDS research study will assess an investigational drug for its effectiveness in the treatment of type 2 diabetes in adolescents.
The rate of type 2 diabetes in adolescents continues to rise. Currently, metformin is the only oral drug recommended as the initial medical treatment for type 2 diabetes in adolescents; however, metformin is not suitable for all adolescents. Hence, there is a need for more treatment options for adolescents with type 2 diabetes.
Metabolism is a major component of health, especially infant health. Scientists are not sure how metabolism is inherited or what factors after birth may influence metabolism, so researchers at Pennington Biomedical are working to better understand the factors that impact metabolism development in infants.
The purpose of the CAMP pilot research study (Caffeine and Albuterol's Effect on Muscle Production) is to determine the effect of an investigational combination of caffeine and albuterol, taken three times daily, on muscle, fat and hunger in obese adolescents ages 12-17. Albuterol is FDA-approved for the treatment of asthma in adolescents but is not approved to affect muscle and body fat in adolescents in combination with caffeine.
The rate of obesity in adolescents continues to rise. Currently, there is only one drug approved for the management of obesity in adolescents; however the drug is not suitable for everyone. There is a need for more options to help obese adolescents lose weight.
The NN8022-4180 research study will assess the safety and effectiveness of a study drug (Liraglutide) for use in the management of obesity in adolescents.
Type 1 diabetes is the most common form of diabetes in children and adolescents. Currently, people with type 1 diabetes rely on insulin shots based on constant blood sugar checks, diet and exercise. There is a need for more treatment options for people with type 1 diabetes.
The T1GER research study will assess a study drug (Golimumab) for the treatment of type 1 diabetes in children and adolescents.
This TDR14311 research study will assess an investigational drug (Lixisenatide) for the treatment of type 2 diabetes in adolescents.
The rate of type 2 diabetes in adolescents continues to rise. Currently, metformin is the only oral drug recommended as the initial medical treatment for type 2 diabetes in adolescents; however, metformin is not suitable for all adolescents. Therefore, there is a need for more treatment options for adolescents with type 2 diabetes.
The TIGER Kids study is researching ways to increase kids' physical activity and reduce sedentary behavior (help kids move more and sit less) to help improve their overall health.
This study is using state-of-the-art technology, including activity trackers and global positioning system (GPS) to monitor physical activity, imaging to measure body fat, and messages sent through a mobile phone app to identify what motivates or prevents kids from being physically active.
***Researchers are currently seeking children who are overweight or obese to participate***
If you’re 18 or older, there may be other studies that you can join. Click here to find out about these studies or call 225-763-3000 to learn how you can be a volunteer!
If you don't see a trial that fits your interests or needs, click here to complete a questionnaire and we will contact you about any future trials for which you may qualify.